Table 2 Baseline characteristics of included articles
From: Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review
Ref. | Period | Type of study | Neoadjuvant therapy | No. of patients, male (%) | Mean age, years (range) | Quality score (Newcastle-Ottawa) |
|---|---|---|---|---|---|---|
Elias et al. [14] | 1998–2002 | Retrospective cohort | Systemic chemotherapy ± HAI | 104 (n/a) | 52 (40–63) | 7 |
Benoist et al. [13] | 1998–2004 | Prospective cohort | Systemic chemotherapy | 586 (68.4) | 61 (n.s.) | 7 |
Elias et al. [15] | 1999–2004 | Retrospective cohort | Systemic chemotherapy ± HAI | 228 (37.5) | 59 (41–70) | 7 |
Auer et al. [16] | 2000–2003 | Retrospective cohort | Systemic chemotherapy ± HAI | 435 (73) | 53 (n.s.) | 9 |
Tanaka et al. [17] | 1998–2007 | Retrospective cohort | Systemic chemotherapy ± HAI | 63 (73.9) | 62 (46–77) | 9 |
Goèré et al. [18] | 1999–2007 | Retrospective cohort | Systemic chemotherapy ± HAI | 523 (40.7) | 52.4 (n.s.) | 7 |
van Vledder et al. [19] | 2000–2008 | Retrospective cohort | Systemic chemotherapy ± biological agents | 168 (n.s.) | n.s. | 9 |
Ferrero et al. [20] | 2004–2008 | Retrospective cohort | Systemic chemotherapy | 171 (75) | 62 (n.s.) | 7 |
Park et al. [21] | 2008–2011 | Retrospective cohort | Systemic chemotherapy ± biological agents | 87 (77.1) | 58.6 (n.s.) | 7 |
Kim et al. [22] | 2010–2012 | Retrospective cohort | Systemic chemotherapy ± biological agents | 137 (77.8) | 60.3 (n.s.) | 8 |
Arita et al. [23] | 2011–2012 | Retrospective cohort | Systemic chemotherapy ± biological agents | 72 (69.4) | 61 (42–81) | 6 |
Owen et al. [24] | 2008–2014 | Retrospective cohort | Systemic chemotherapy ± biological agents | 23 (n.s.) | 53 (37–74) | 7 |
Tani et al. [9] | 2010–2014 | Retrospective cohort | Systemic chemotherapy ± biological agents | 82 (50) | 57.5 (34–77) | 6 |
Sturesson et al. [25] | 2011–2014 | Retrospective cohort | Systemic chemotherapy ± biological agents | 179 (70) | 68 (48–83) | 7 |
Oba et al. [8] | 2010–2015 | Retrospective cohort | Systemic chemotherapy ± biological agents | 184 (71) | 59 (30–81) | 6 |